Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

ClinicalTrials.gov ID: NCT05321420

Public ClinicalTrials.gov record NCT05321420. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 8:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double-blind, Four-Arm Active and Placebo-controlled Dose-Finding Trial to Evaluate the Efficacy, Tolerability, Safety and Dose Response of LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study a randomized, double-blind, four arm study to evaluate the safety and efficacy of LYT-100 compared to pirfenidone or placebo in adults with Idiopathic Pulmonary Fibrosis.

Study identification

NCT ID
NCT05321420
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
PureTech
Industry
Enrollment
240 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 22, 2022 (Actual)
Primary completion
Oct 15, 2024 (Actual)
Completion
Dec 31, 2025 (Estimated)
Last update posted
Oct 16, 2025

2022 – 2025

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
University of Alabama Birmingham Birmingham Alabama 35294 —
Science 37 Los Angeles California 90230 —
NewportNativeMD, Inc. Newport Beach California 92663 —
Paradigm Clinical Research Centers, Inc. Redding California 96001 —
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center Torrance California 90502 —
University of Connecticut Health Center Farmington Connecticut 06030 —
Accel Research Sites Network DeLand Florida 32720 —
Harmony Medical Research Institute, Inc Hialeah Florida 33016 —
Piedmont Healthcare, Inc. Atlanta Georgia 30309 —
Clinical Research Investments Decatur Georgia 30030 —
Indiana University School of Medicine Indianapolis Indiana 46202 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Pulmonix Greensboro North Carolina 27403 —
Southeastern Research Center Winston-Salem North Carolina 27103 —
University of Cincinnati Cincinnati Ohio 45267 —
Temple University Philadelphia Pennsylvania 19140 —
Clinical Trials Center of Middle Tennessee Franklin Tennessee 37067 —
Vanderbilt University Medical Center Nashville Tennessee 37204 —
Baylor Scott & White Research Institute Dallas Texas 75204 —
Renovatio Clinical - The Woodlands Research Center The Woodlands Texas 77380 —
Pulmonary Associates of Richmond Richmond Virginia 23230 —
TPMG Clinical Research Williamsburg Virginia 23188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 81 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05321420, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 16, 2025 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05321420 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →